{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T03:37:19Z","timestamp":1788233839382,"version":"build-2803163510"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,7]]},"abstract":"<jats:sec>\n            <jats:title>Background.<\/jats:title>\n            <jats:p>The pathology-based diagnosis of cardiac antibody-mediated rejection (AMR) relies on the 2013 International Society for Heart and Lung Transplantation Working Formulation, in which microvascular inflammation (MVI) is considered as present or absent regardless of its extent. This work assessed the biological and clinical value of a semiquantitative evaluation of the extent of MVI in endomyocardial biopsies (EMBs).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods.<\/jats:title>\n            <jats:p>We retrospectively graded the extent of MVI in 291 EMB from 291 patients according to a 4-point scale in which MVI scores of 0, 1, 2, and 3 represented 0%, 1%\u201310%, 11%\u201350%, and &gt;50% of the myocardial area, respectively. We analyzed the association between the MVI score and tissue rejection molecular activity assessed by microarrays or reverse transcriptase multiplex ligation-dependent probe amplification, current pathology classification (pathologic AMR [pAMR]), anti-HLA donor-specific antibodies, and graft dysfunction.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results.<\/jats:title>\n            <jats:p>Overall, 172 (59.1%), 33 (11.4%), 42 (14.4%), and 44 (15.1%) EMB were given MVI scores of 0, 1, 2, and 3, respectively. pAMR1(H+) and pAMR2\/3 categories were found to be heterogeneous in terms of MVI score. Acute cellular rejection grades did not influence the MVI score. In both molecular approaches, we observed a stepwise increase in the expression of AMR-related transcripts with increasing MVI scores, independent of the C4d or CD68 status (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001). Both the frequency and mean fluorescence intensity of donor-specific antibodies gradually increased with the MVI score (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001). Acute graft dysfunction was more frequent in MVI score 3 (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions.<\/jats:title>\n            <jats:p>The intensity of MVI in EMB, based on a semiquantitative evaluation of its extent, has biological and clinical importance.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/tp.0000000000004008","type":"journal-article","created":{"date-parts":[[2021,12,26]],"date-time":"2021-12-26T18:01:14Z","timestamp":1640541674000},"page":"1455-1464","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":9,"title":["Correlation Between Microvascular Inflammation in Endomyocardial Biopsies and Rejection Transcripts, Donor-specific Antibodies, and Graft Dysfunction in Antibody-mediated Rejection"],"prefix":"10.1097","volume":"106","author":[{"given":"Guillaume","family":"Coutance","sequence":"first","affiliation":[{"name":"Department of Cardiac and Thoracic Surgery, Cardiology Institute, Pitie\u0301 Salpe\u0302trie\u0300re Hospital, Assistance Publique-H\u00f4pitaux de Paris (AP-HP). Sorbonne University Medical School, Paris, France."},{"name":"Paris Translational Research Centre for Organ Transplantation, INSERM, UMR-S970, Paris, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilyass","family":"Zouhry","sequence":"additional","affiliation":[{"name":"Pathology Department, H\u00f4pital Necker, Assistance Publique - H\u00f4pitaux de Paris, Paris, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maud","family":"Racap\u00e9","sequence":"additional","affiliation":[{"name":"Paris Translational Research Centre for Organ Transplantation, INSERM, UMR-S970, Paris, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanny","family":"Drieux","sequence":"additional","affiliation":[{"name":"INSERM U1245, Centre Henri Becquerel, Rouen, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Julien","family":"Viailly","sequence":"additional","affiliation":[{"name":"INSERM U1245, Centre Henri Becquerel, Rouen, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Rouvier","sequence":"additional","affiliation":[{"name":"Pathology Department, La Piti\u00e9 Salp\u00e9tri\u00e8re, Assistance Publique - H\u00f4pitaux de Paris, Paris, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Fran\u00e7ois","sequence":"additional","affiliation":[{"name":"Pathology Department, Rouen University Hospital, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Pierre","family":"Chenard","sequence":"additional","affiliation":[{"name":"Pathology Department, Strasbourg University Hospital, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Toquet","sequence":"additional","affiliation":[{"name":"Pathology Department, Nantes University Hospital, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Rabant","sequence":"additional","affiliation":[{"name":"Pathology Department, H\u00f4pital Necker, Assistance Publique - H\u00f4pitaux de Paris, Paris, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald J.","family":"Berry","sequence":"additional","affiliation":[{"name":"Department of Pathology, Stanford University School of Medicine, Stanford, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Angelini","sequence":"additional","affiliation":[{"name":"Department of Cardiac, Thoracic and Vascular Sciences and Public Health, University of Padua, Padua, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Bruneval","sequence":"additional","affiliation":[{"name":"Paris Translational Research Centre for Organ Transplantation, INSERM, UMR-S970, Paris, France."},{"name":"Universit\u00e9 de Paris, Paris, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Paul","family":"Duong Van Huyen","sequence":"additional","affiliation":[{"name":"Paris Translational Research Centre for Organ Transplantation, INSERM, UMR-S970, Paris, France."},{"name":"Pathology Department, H\u00f4pital Necker, Assistance Publique - H\u00f4pitaux de Paris, Paris, France."},{"name":"Universit\u00e9 de Paris, Paris, France."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,12,21]]},"reference":[{"key":"R1-20250607","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1681\/ASN.2017070749","article-title":"Dynamic prognostic score to predict kidney allograft survival in patients with antibody-mediated rejection.","volume":"29","author":"Viglietti","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"R2-20250607","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.healun.2016.04.007","article-title":"The effect of timing and graft dysfunction on survival and cardiac allograft vasculopathy in antibody-mediated rejection.","volume":"35","author":"Clerkin","year":"2016","journal-title":"J Heart Lung Transplant"},{"key":"R3-20250607","first-page":"430","article-title":"Vascular (humoral) rejection in heart transplantation: pathologic observations and clinical implications.","volume":"8","author":"Hammond","year":"1989","journal-title":"J Heart Transplant"},{"key":"R4-20250607","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1111\/ajt.13589","article-title":"Antibody-mediated rejection in lung transplantation: clinical outcomes and donor-specific antibody characteristics.","volume":"16","author":"Roux","year":"2016","journal-title":"Am J Transplant"},{"key":"R5-20250607","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.healun.2012.10.007","article-title":"Donor-specific antibodies are associated with antibody-mediated rejection, acute cellular rejection, bronchiolitis obliterans syndrome, and cystic fibrosis after lung transplantation.","volume":"32","author":"Lobo","year":"2013","journal-title":"J Heart Lung Transplant"},{"key":"R6-20250607","first-page":"2580","article-title":"Antibody-mediated rejection of solid-organ allografts.","volume":"379","author":"Lefaucheur","year":"2018","journal-title":"N Engl J Med"},{"key":"R7-20250607","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/ajt.14625","article-title":"The Banff 2017 Kidney Meeting report: revised diagnostic criteria for chronic active T cell-mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials.","volume":"18","author":"Haas","year":"2018","journal-title":"Am J Transplant"},{"key":"R8-20250607","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1097\/TP.0000000000002366","article-title":"A 2018 reference guide to the Banff classification of renal allograft pathology.","volume":"102","author":"Roufosse","year":"2018","journal-title":"Transplantation"},{"key":"R9-20250607","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1111\/ajt.13909","article-title":"2016 Comprehensive update of the Banff Working Group on liver allograft pathology: introduction of antibody-mediated rejection.","volume":"16","author":"Demetris","year":"2016","journal-title":"Am J Transplant"},{"key":"R10-20250607","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/ajt.14990","article-title":"Banff lung report: current knowledge and future research perspectives for diagnosis and treatment of pulmonary antibody-mediated rejection (AMR).","volume":"19","author":"Roux","year":"2019","journal-title":"Am J Transplant"},{"key":"R11-20250607","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.healun.2013.08.011","article-title":"The 2013 International Society for Heart and Lung Transplantation Working Formulation for the standardization of nomenclature in the pathologic diagnosis of antibody-mediated rejection in heart transplantation.","volume":"32","author":"Berry","year":"2013","journal-title":"J Heart Lung Transplant"},{"key":"R12-20250607","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/ajt.12976","article-title":"Inflammatory cell burden and phenotype in endomyocardial biopsies with antibody-mediated rejection (AMR): a multicenter pilot study from the AECVP.","volume":"15","author":"Fedrigo","year":"2015","journal-title":"Am J Transplant"},{"key":"R13-20250607","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/ajt.14112","article-title":"The XIIIth Banff Conference on Allograft Pathology: the Banff 2015 Heart Meeting report: improving antibody-mediated rejection diagnostics: strengths, unmet needs, and future directions.","volume":"17","author":"Bruneval","year":"2017","journal-title":"Am J Transplant"},{"key":"R14-20250607","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.healun.2005.09.003","article-title":"Acute antibody-mediated rejection of cardiac transplants.","volume":"25","author":"Reed","year":"2006","journal-title":"J Heart Lung Transplant"},{"key":"R15-20250607","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1161\/CIRCULATIONAHA.116.022907","article-title":"Gene expression profiling for the identification and classification of antibody-mediated heart rejection.","volume":"135","author":"Loupy","year":"2017","journal-title":"Circulation"},{"key":"R16-20250607","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.healun.2017.05.029","article-title":"Building a tissue-based molecular diagnostic system in heart transplant rejection: the heart Molecular Microscope Diagnostic (MMDx) System.","volume":"36","author":"Halloran","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"R17-20250607","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.healun.2019.11.010","article-title":"Reverse transcriptase multiplex ligation-dependent probe amplification in endomyocardial biopsies for the diagnosis of cardiac allograft rejection.","volume":"39","author":"Adam","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"R18-20250607","doi-asserted-by":"crossref","first-page":"3308","DOI":"10.1111\/ajt.16083","article-title":"The XVth Banff Conference on Allograft Pathology the Banff Workshop Heart Report: improving the diagnostic yield from endomyocardial biopsies and quilty effect revisited.","volume":"20","author":"Huyen","year":"2020","journal-title":"Am J Transplant"},{"key":"R19-20250607","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.healun.2010.05.034","article-title":"The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients.","volume":"29","author":"Costanzo","year":"2010","journal-title":"J Heart Lung Transplant"},{"key":"R20-20250607","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/j.healun.2005.03.019","article-title":"Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection.","volume":"24","author":"Stewart","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"R21-20250607","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.jmoldx.2017.07.007","article-title":"Determination of molecular subtypes of diffuse large B-cell lymphoma using a reverse transcriptase multiplex ligation-dependent probe amplification classifier: a CALYM study.","volume":"19","author":"Bob\u00e9e","year":"2017","journal-title":"J Mol Diagn"},{"key":"R22-20250607","doi-asserted-by":"crossref","first-page":"e153","DOI":"10.1093\/nar\/gng153","article-title":"Expression profiling via novel multiplex assay allows rapid assessment of gene regulation in defined signalling pathways.","volume":"31","author":"Eldering","year":"2003","journal-title":"Nucleic Acids Res"},{"key":"R23-20250607","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/nrneph.2016.85","article-title":"Molecular assessment of disease states in kidney transplant biopsy samples.","volume":"12","author":"Halloran","year":"2016","journal-title":"Nat Rev Nephrol"},{"key":"R24-20250607","doi-asserted-by":"crossref","first-page":"e0167213","DOI":"10.1371\/journal.pone.0167213","article-title":"Myocardial gene expression profiling to predict and identify cardiac allograft acute cellular rejection: the GET-study.","volume":"11","author":"Bodez","year":"2016","journal-title":"PLoS One"},{"key":"R25-20250607","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/ajt.14600","article-title":"Review: the transcripts associated with organ allograft rejection.","volume":"18","author":"Halloran","year":"2018","journal-title":"Am J Transplant"},{"key":"R26-20250607","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1111\/ajt.12150","article-title":"Molecular diagnosis of antibody-mediated rejection in human kidney transplants.","volume":"13","author":"Sellar\u00e9s","year":"2013","journal-title":"Am J Transplant"},{"key":"R27-20250607","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1161\/CIR.0000000000000093","article-title":"Antibody-mediated rejection in cardiac transplantation: emerging knowledge in diagnosis and management: a scientific statement from the American Heart Association.","volume":"131","author":"Colvin","year":"2015","journal-title":"Circulation"},{"key":"R28-20250607","doi-asserted-by":"crossref","first-page":"e553","DOI":"10.1161\/CIR.0000000000000598","article-title":"Sensitization in heart transplantation: emerging knowledge: a scientific statement from the American Heart Association.","volume":"139","author":"Colvin","year":"2019","journal-title":"Circulation"},{"key":"R29-20250607","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.healun.2018.01.1291","article-title":"The management of antibodies in heart transplantation: an ISHLT consensus document.","volume":"37","author":"Kobashigawa","year":"2018","journal-title":"J Heart Lung Transplant"},{"key":"R30-20250607","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/ajt.12162","article-title":"A survey of current practice for antibody-mediated rejection in heart transplantation.","volume":"13","author":"Chih","year":"2013","journal-title":"Am J Transplant"},{"key":"R31-20250607","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1111\/ajt.15898","article-title":"The Banff 2019 Kidney Meeting report (I): updates on and clarification of criteria for T cell- and antibody-mediated rejection.","volume":"20","author":"Loupy","year":"2020","journal-title":"Am J Transplant"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000004008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T16:11:28Z","timestamp":1749312688000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000004008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,21]]},"references-count":31,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000004008","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12,21]]}}}